Valeant Pharmaceuticals (VRX) Stock: Headed Up On Strong Guidance!

Valeant Pharmaceuticals Intl Inc (NYSE: VRX) is having an overwhelmingly strong start to the trading session in the pre-market hours this morning after reporting its financial results for the first quarter, increasing guidance and announcing a name change. Ultimately, the news led to excitement among investors, sending the stock on a run for the top. … Read more

Valeant Pharmaceuticals (VRX) Stock: Falling Hard On Earnings And Guidance

Valeant Pharmaceuticals Intl Inc (NYSE: VRX) is having an overwhelmingly rough start to the trading session this morning, and for good reason. The company reported its financial results for the fourth quarter, missing expectations. To make matters worse, the company released guidance that simply didn’t meet up with what investors wanted to see. Today, we’ll talk … Read more

Valeant Pharmaceuticals (VRX) Stock: Gaining On Strong Earnings

Valeant Pharmaceuticals Intl Inc (NYSE: VRX) is having an overwhelmingly strong day in the market today, and for good reason. The company announced its earnings for the third quarter, blowing away expectations and exciting investors. Today, we’ll talk about what we saw from earnings, how the stock reacted in the market, and what we’ll be … Read more

Valeant Pharmaceuticals (VRX) Stock: Gaining On FDA Approval

Valeant Pharmaceuticals Intl Inc (NYSE: VRX) is having an overwhelmingly strong start to the trading session this morning in the pre-market hours, and for good reason. The company announced that its wholly owned subsidiary, Bausch + Lomb, in conjunction with Nicox S.A., has received FDA approval for a key treatment. Of course, this led to … Read more

Valeant Pharmaceuticals (VRX) Stock: Gaining On Earnings And Rumors

Valeant Pharmaceuticals Intl Inc (NYSE: VRX) is having an overwhelmingly strong time in the pre-market hours, which is interesting considering that the company reported its second quarter earnings, and while the report showed a further decline in revenue, investors are taking it as positive. As is normally the case, our partners at Trade Ideas were … Read more

Valeant Pharmaceuticals (VRX) Stock: Gaining On iNova Pharmaceuticals Sale

Valeant Pharmaceuticals Intl Inc (NYSE: VRX) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company announced that sale of its iNova Pharmaceuticals business, causing excitement among investors who sent the stock upward. Of course, our partners at Trade Ideas were the first to alert us to … Read more